BorsaDEX+
Kripto AlPiyasalarSpotVadeli İşlemlerGOLDBirikimEtkinlik Merkezi
Daha Fazla
Commodity Zero-Fee Gala
CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generationCARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation

Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium

Yazar: AI Journal
Kaynak: AI Journal
2026/02/24 06:45
Okuma süresi: 3 dk
WorldAssets
INC$0.4994-2.47%

CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that two abstracts have been accepted for presentation at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (ASCO GU). The meeting is being held February 26-28, 2026, in San Francisco, California.

Details of the poster presentations are below:

Title: “ctDNA monitoring of FGFR3-altered metastatic urothelial cancer treated with dabogratinib (formerly TYRA-300) in the SURF301 trial“

  • Abstract Number: 809
  • Session: Poster Session B: Prostate Cancer and Urothelial Carcinoma
  • Date and Time: February 27, 2026, 11:30 AM–12:45 PM PST
  • Presenting Author: Andrew J. Murtha, BSc, University of British Columbia, Vancouver, BC, Canada

Title: “A phase 2 multicenter, open-label study evaluating the efficacy and safety of dabogratinib (formerly TYRA-300) in participants with FGFR3-altered low-grade, intermediate risk non-muscle invasive bladder cancer (SURF302)“

  • Abstract Number: TPS886
  • Session: Trials in Progress Poster Session B: Urothelial Carcinoma
  • Date and Time: February 27, 2026, 11:30 AM–12:45 PM PST
  • Presenting Author: Gautam Jayram, MD, Urology Associates, Nashville, TN

More information can be found at the ASCO GU website. The posters will be available on the IR page of TYRA’s website following presentation at ASCO GU: https://ir.tyra.bio.

About Tyra Biosciences

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA’s in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA’s expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA’s lead precision medicine stemming from SNÅP, oral dabogratinib, is a potential first-in-class selective FGFR3 inhibitor. Oral dabogratinib’s current planned clinical development includes three Phase 2 studies: SURF303 for low-grade upper tract urothelial carcinoma, SURF302 for intermediate risk non-muscle invasive bladder cancer, and BEACH301 for pediatric achondroplasia. TYRA is also developing TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational, FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in Carlsbad, CA.

For more information about our science, pipeline and people, please visit www.tyra.bio and engage with us on LinkedIn.

Contact:
Amy Conrad
aconrad@tyra.bio

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tyra-biosciences-announces-poster-presentations-at-the-2026-asco-genitourinary-gu-cancers-symposium-302695042.html

SOURCE Tyra Biosciences

Piyasa Fırsatı
WorldAssets Logosu
WorldAssets Fiyatı(INC)
$0.4994
$0.4994$0.4994
-0.89%
USD
WorldAssets (INC) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

MetaMask to Integrate Hyperliquid’s Perpetuals In-Wallet Following mUSD Launch

MetaMask to Integrate Hyperliquid’s Perpetuals In-Wallet Following mUSD Launch

The post MetaMask to Integrate Hyperliquid’s Perpetuals In-Wallet Following mUSD Launch appeared on BitcoinEthereumNews.com. Crypto wallet MetaMask looks set to integrate Hyperliquid’s perpetuals trading on its platform. This development follows the wallet’s rollout of its mUSD stablecoin and amid plans to launch a native token. MetaMask To Launch Hyperliquid’s Perpetuals In-Wallet GitHub documents show that the wallet plans to integrate Hyperliquid perpetuals trading with deposit functionality. The pull request showed the implementation of a change that would enable users to deposit USDC from their wallet to their Perps trading account. This development follows the launch of MetaMask’s mUSD stablecoin, which could also play a major role in this integration. It is worth mentioning that the crypto wallet platform won’t be the first to integrate Hyperliquid’s Perps. In July earlier this year, Solana wallet Phantom introduced in-wallet perpetual futures trading with over 100 markets and leverage through its partnership with the decentralized exchange. Meanwhile, it is worth mentioning that MetaMask has yet to reveal when it will roll out this Hyperliquid feature. Crypto researcher Eric predicts that this could happen in the next couple of weeks and that the crypto wallet platform may announce it at the Token 2049 Conference during the Hypurreco event. He further remarked that MetaMask may reveal a points campaign alongside the Hyperliquid announcement, having confirmed that they are launching a token. Eric added that “all roads lead to Hyperliquid.” This could mark another major win for Hyperliquid’s adoption, considering the number of users that the wallet boasts. Notably, USDC issuer Circle just announced its HYPE investment and the launch of native USDC on Hyperliquid’s network, HyperEVM. Integration Could Double The DEX’s Perps Volume In an X post, market expert Ryan predicted that MetaMask’s integration could double Hyperliquid’s $8 billion to $10 billion daily perpetuals volume if all its users participate in using the trading product. He added that it could…
Paylaş
BitcoinEthereumNews2025/09/20 00:53
Scott Bessent says yuan drop against euro is Europe’s problem, not America’s

Scott Bessent says yuan drop against euro is Europe’s problem, not America’s

The post Scott Bessent says yuan drop against euro is Europe’s problem, not America’s appeared on BitcoinEthereumNews.com. U.S. Treasury Secretary Scott Bessent said in Madrid on Thursday that the slump in China’s currency isn’t a problem for the United States, it’s Europe that should be worried. Speaking during a joint interview with Reuters and Bloomberg, Scott made the comments after meetings with Chinese Vice Premier He Lifeng as part of the U.S.-China trade discussions, which also included talks on TikTok. He made it clear that the yuan, also known as the renminbi, has actually strengthened against the U.S. dollar this year, but collapsed to a record low against the euro. “The RMB is actually stronger this year versus the dollar. Now it’s at an all-time low versus the euro, which is a problem for the Europeans,” Scott, rejecting the idea that Beijing was trying to devalue its currency to gain an unfair edge against Washington. He said Chinese officials haven’t tried anything of the sort with the U.S. and explained the reality behind the currency’s movement: “It’s a closed currency. So they manage the level.” Yuan collapse helps Chinese exports flood europe Since January, the yuan has plunged from 7.5 per euro to over 8.4, triggering concerns across Europe. Meanwhile, against the dollar, it’s gained slightly from 7.3 to 7.1. This divergence has created a lopsided trade dynamic, because while the U.S. has seen its imports from China drop 14% due to aggressive tariffs, Europe has recorded a 6.9% increase in trade with China. So, Scott said the U.S. tariffs are doing what they were meant to do, cutting down the trade deficit. But the redirected flow of Chinese goods is now landing in European markets instead, where the yuan’s weakness is making Chinese exports even cheaper in euro terms. The weakening of the yuan is hitting Europe at a sensitive time, as the European Central Bank…
Paylaş
BitcoinEthereumNews2025/09/19 10:16
Vietnam US Tariffs: The Stunning ASEAN Winner Emerges as Manufacturing Shifts Accelerate

Vietnam US Tariffs: The Stunning ASEAN Winner Emerges as Manufacturing Shifts Accelerate

BitcoinWorld Vietnam US Tariffs: The Stunning ASEAN Winner Emerges as Manufacturing Shifts Accelerate HANOI, VIETNAM – March 2025: Vietnam stands poised as the
Paylaş
bitcoinworld2026/02/24 07:05